Banque Cantonale Vaudoise »

Kyverna Therapeutics shares owned by Banque Cantonale Vaudoise

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Banque Cantonale Vaudoise from 13F filings

Historical chart of Banque Cantonale Vaudoise investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Banque Cantonale Vaudoise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Banque Cantonale Vaudoise

Quarter filed Position value Share count Share price at filing
2026-03-31 $263k 31k 8.61

More positions owned by Banque Cantonale Vaudoise

Ubs Group SHS (UBS)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amrize SHS (AMRZ)
Amazon (AMZN)
Visa Com Cl A (V)
Logitech Intl S A SHS (LOGI)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)

View all positions for Banque Cantonale Vaudoise

Top funds holding Kyverna Therapeutics

Gilead Sciences
Bain Capital Life Sciences Investors
Deerfield Management Company
Vanguard Group
Adage Capital Partners GP
AIGH Capital Management
Insight Holdings
Balyasny Asset Management
Woodline Partners
Propel Bio Management
Mbb Public Markets I
Alyeska Investment Group
Millennium Management
BlackRock
D. E. Shaw & Co

View all funds holding Kyverna Therapeutics